mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.009 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.01 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
-0.5 |
0.01 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |